期刊文献+

抗结核药物诱导肝损伤的影响因素探讨 被引量:11

Influence Factors of Liver Injury Induced by Anti-tuberculosis Drugs
下载PDF
导出
摘要 目的:探讨抗结核药物诱导肝损伤的影响因素。方法:采用问卷调查和查阅病历的方法,调查516例初治结核病患者,内容包括人口学特征、个人疾病史、结核病治疗期间合并使用其他药物史、健康相关行为等,按照相关标准将在6个月观察期内发生肝损伤者定义为"病例组",未发生肝损伤者定义为"对照组",采用Logistic回归分析探讨这些因素对抗结核药物诱导肝损伤的影响。结果:多因素Logistic回归分析结果提示,与抗结核药物诱导肝损伤显著关联的因素是女性(OR=0.616;95%CI=0.398~0.954)、食鱼生行为(OR=2.072;95%CI=1.273~3.373)、肺外结核(OR=6.122;95%CI=1.684~22.262)、乙肝表面抗原阳性(OR=4.202;95%CI=2.349~7.517)和低蛋白血症(OR=2.012;95%CI=1.146~3.532)。结论:抗结核药物诱导肝损伤受多方面因素的影响。 Objective: To explore the influence factors of liver injury induced by anti-tuberculosis drugs. Method: 516 tuberculosis patients newly diagnosed were investigated with a structure questionnaire and reading case history about their demographics, individual disease history, history of other drugs used in the period of anti-tuberculosis treatments, health-related behaviors, etc. Logistic regression analyses were conducted to explore the impact of these factors on liver injury caused by anti-tuberculosis treatments. Result: The results of multivariate logistic regression analyses indicated that the following factors were significantly associated with liver injury caused by anti-tuberculosis drugs. The patients associated with the liver injury were female ( OR = 0. 616 ; 95% CI = 0. 398 - 0. 954 ), eating undercooked freshwater fishes ( OR = 2. 072 ; 95% CI = 1. 273 - 3. 373 ), extra-pulmonary tuberculosis ( OR = 6. 122 ;95% C = 1. 684 - 22. 262 ), positive serum hepatitis B virus surface antigen ( OR = 4. 202 ; 95% CI = 2. 349 - 7. 517 ) and hypo-albuminemia ( OR = 2. 012 ; 95% CI = 1. 146 - 3. 532). Conclusion: The anti-tuberculosis drug-induced liver injury is affected by multiple factors.
出处 《药物流行病学杂志》 CAS 2008年第6期377-380,共4页 Chinese Journal of Pharmacoepidemiology
关键词 抗结核药物 诱导 肝损伤 影响因素 Anti-tuberculosis drug Induce Liver injury Influence factor
  • 相关文献

参考文献15

二级参考文献47

  • 1侯恕.呼吸疾病的营养支持(现代呼吸系疾病系统讲座第十讲)[J].中华结核和呼吸杂志,1996,19(3):133-135. 被引量:49
  • 2中华医学会结核病学分会.中国结核病分类法[J].中华结核和呼吸杂志,1998,21(12):716-716. 被引量:285
  • 3高殿举,曲桂香,张丽.抗结核药物对肝脏损害69例临床观察分析[J].吉林医学院学报,1997,17(2):43-45. 被引量:6
  • 4Larrey D, Erlinger S, Krishnasuamy K, et al. Hepatic dysfunction in undernourished patients receiving in soniazid and rifarnpicin[J]. Baillieres Clin Gastroenterol, 1998,23 (4):423-431 被引量:1
  • 5Turktas H,Unsal M,Tulek N, et al. Hpatotoxicity of antituberculosis therapy (rifampicin, isoniazidand and pyrazinamide) or viral hepatitis [J]. Tuberc Lung Dis. 1994, 75(1): 58-60 被引量:1
  • 6Miller MS, McCarver DC, Bell DA, et al. Toxic hepatitis with isoniazd and rifampin [J]. Fundam Appl Tocicol,1999,40(l)1-14 被引量:1
  • 7Pessyre D, Bentata M, Degott C. Isoniazid-rifampin fulminant hepatitis: a possible consequence of enhancement of isoniazid hepatotoxicity by enzyme induction [J]. gasteoenterol, 1997,131(2): 284-292 被引量:1
  • 8Kaplovitz N. Drug-induced liver disorders: implication for drug development and regulation [J]. Drug Sa f, 2001,24(2) :483-490 被引量:1
  • 9Bissell DM, Gores GJ, Laskin DL, et al. Drug-induced liver injury: mechanisms and test systerms [J]. Hepatology,2001,33(9): 1009-1013 被引量:1
  • 10Zimmerman HJ. Drug-induced liver disease. In: Schiff ER,Sorrell MF, MaddreyWC, eds. Schiff' s diseases of the liver.New York: Lippincott-Raven, 1998. 973-1004 被引量:1

共引文献3147

同被引文献106

引证文献11

二级引证文献113

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部